Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2,3 Dehydrosilybin
2. 2,3-dehydrosilybin
3. Alepa Forte
4. Alepa-forte
5. Ardeyhepan
6. Cefasilymarin
7. Durasilymarin
8. Hepa Loges
9. Hepa Merz Sil
10. Hepa-loges
11. Hepa-merz Sil
12. Hepabesch
13. Hepar Pasc
14. Hepar-pasc
15. Heparsyx
16. Heplant
17. Lagosa
18. Legalon Forte
19. Silibin
20. Silibinin
21. Silibinin A
22. Silibinin B
23. Silybin A
24. Silybin B
25. Silybinin
26. Carsil
27. Karsil
28. Legalon
29. Silimarin
30. Silymarin
1. Silybin A,b (mixture)
2. 802918-57-6
3. Silybin (a+b)
4. (2r,3r)-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one
5. Legalon
6. Silibin
7. Silliver
8. Silybine
9. Silymarin
10. Chembl9509
11. Silibinin A-silibinin B Mixt.
12. Schembl14270800
13. Schembl22398934
14. Hy-n0779a
15. Cs-0138778
16. S0508
17. E80721
18. Silybin (mixture Of Silybin A And B) 100 Microg/ml In Acetonitrile
19. (2r,3r)-2,3-dihydro-3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-1,4-benzodioxin-6-yl]-4h-1-benzopyran-4-one
20. 2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxine
Molecular Weight | 482.4 g/mol |
---|---|
Molecular Formula | C25H22O10 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 482.12129689 g/mol |
Monoisotopic Mass | 482.12129689 g/mol |
Topological Polar Surface Area | 155 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 750 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Protective Agents
Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. (See all compounds classified as Protective Agents.)
A - Alimentary tract and metabolism
A05 - Bile and liver therapy
A05B - Liver therapy, lipotropics
A05BA - Liver therapy
A05BA03 - Silymarin
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?